AI Cancer Vaccine Startup Gamgee Raises $4M Led by Founders Fund
新智元 · wechat · 2026-08-23
After using AI (ChatGPT and AlphaFold) to design a personalized mRNA cancer vaccine that shrank his dog Rosie's tumor by 75%, developer Paul Conyngham founded Gamgee to industrialize the process, despite Rosie's passing due to production delays.
Business Progress:
- Funding: Raised $4M seed round led by Founders Fund with participation from YC.
- Model: Building a SaaS platform to reduce vaccine design time to 48 hours, targeting a $2,000 end-to-end cost.
- Vision: Addressing the needs of 6 million dogs with cancer in the US first, leveraging a data flywheel to improve models, with plans to expand to human "N-of-1" personalized medicine.
Related event: Founder Who Used AI to Design Cancer Vaccine for His Dog Raises $4M(2 posts)→
More from Venture
- CNN signs multi-year AI licensing partnership with Google for generative AI experiments — gaganghotra_ · 2026-10-16
- Zymtrace raises $12.2M and hires ML engineers to build agents that fix GPU bottlenecks — cfregly · 2026-10-16
- FT: Risk of an AI crunch for stock markets is rising — nordicinst · 2026-10-16
- Haight Street Compute Market: a one-day trading floor for GPU deals in SF — ctjlewis · 2026-10-16
- OpenAI's 110 London staff averaged £2.3M each in 2025, double the prior year — rohanpaul_ai · 2026-10-16
- Persona Raises $10M Led by Vine Ventures; $179 Wearable Band Expected in December — heyneighbor · 2026-10-16